Increased activity of CHK enhances the radioresistance of MCF-7 breast cancer stem cells

Yang,Zhi‑Xue; Sun,Yi‑Hui; He,Jian‑Gang; Cao,Hua; Jiang,Guo‑Qin

doi:10.3892/ol.2015.3777

Increased activity of CHK enhances the radioresistance of MCF-7 breast cancer stem cells

Authors:
- Zhi‑Xue Yang
- Yi‑Hui Sun
- Jian‑Gang He
- Hua Cao
- Guo‑Qin Jiang
View Affiliations

Affiliations: Department of General Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, P.R. China
Published online on: October 2, 2015 https://doi.org/10.3892/ol.2015.3777
Pages: 3443-3449
Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The resistance of breast cancer to radiotherapy remains a major obstacle to successful cancer management. Radiotherapy may result in DNA damage and activate breast cancer stem cells. DNA damage may lead to activation of the checkpoint kinase (CHK) signaling pathway, of which debromohymenialdisine (DBH) is a specific inhibitor. Radiotherapy also increases the expression of phosphorylated CHK1/2 (pCHK1/2) in the breast cancer cell line, MCF‑7, in vitro in a dose‑dependent manner. DBH is a relatively stable effective inhibitor that significantly reduces pCHK1/2 expression and MCF‑7 proliferation. Low‑dose radiotherapy combined with DBH resulted in a higher MCF‑7 inhibition rate compared with high‑dose radiation alone. This result indicates that the inhibition of the CHK1/2 signal pathway may significantly reduce DNA damage within radiated cells. Radiotherapy may also regulate the proportion of CD44+/CD24‑ MCF‑7 cancer stem cells in a dose‑ and time‑dependent manner. However, the stem cell proportion of MCF‑7 cells was significantly reduced by treatment with DBH. The inhibition is relatively stable and time dependent. Significant reductions were observed after 3 days of culture (P<0.01). The results of the present study indicate that the DBH‑induced downregulation of CHK may provide a novel method of enhancing the effect of radiotherapy and reducing stem cell survival in the MCF-7 cell line.

View Figures

View References

1	Fillmore CM and Kuperwasser C: Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res. 10:R252008. View Article : Google Scholar : PubMed/NCBI
2	Nguyen NP, Almeida FS, Chi A, Nguyen LM, Cohen D, Karlsson U and Vinh-Hung V: Molecular biology of breast cancer stem cells: Potential clinical applications. Cancer Treat Rev. 36:485–491. 2010. View Article : Google Scholar : PubMed/NCBI
3	Pajonk F, Vlashi E and McBride WH: Radiation resistance of cancer stem cells: The 4 R's of radiobiology revisited. Stem Cells. 28:639–648. 2010. View Article : Google Scholar : PubMed/NCBI
4	Kai K, Arima Y, Kamiya T and Saya H: Breast cancer stem cells. Breast Cancer. 17:80–85. 2010. View Article : Google Scholar : PubMed/NCBI
5	Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ and Clarke MF: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
6	Sheridan C, Kishimoto H, Fuchs RK, Mehrotra S, Bhat-Nakshatri P, Turner CH, Goulet R Jr, Badve S and Nakshatri H: CD44⁺/CD24⁻ breast cancer cells exhibit enhanced invasive properties: An early step necessary for metastasis. Breast Cancer Res. 8:R592006. View Article : Google Scholar : PubMed/NCBI
7	Shipitsin M, Campbell LL, Argani P, Weremowicz S, Bloushtain-Qimron N, Yao J, Nikolskaya T, Serebryiskaya T, Beroukhim R, Hu M, et al: Molecular definition of breast tumor heterogeneity. Cancer Cell. 11:259–273. 2007. View Article : Google Scholar : PubMed/NCBI
8	Hwang-Verslues WW, Kuo WH, Chang PH, Pan CC, Wang HH, Tsai ST, Jeng YM, Shew JY, Kung JT, Chen CH, et al: Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers. PLoS One. 4:e83772009. View Article : Google Scholar : PubMed/NCBI
9	Harper JW and Elledge SJ: The DNA damage response: Ten years after. Mol Cell. 28:739–745. 2007. View Article : Google Scholar : PubMed/NCBI
10	Ackerstaff E, Glunde K and Bhujwalla ZM: Choline phospholipid metabolism: A target in cancer cells? J Cell Biochem. 90:525–533. 2003. View Article : Google Scholar : PubMed/NCBI
11	de Ramírez Molina A, Gutiérrez R, Ramos MA, Silva JM, Silva J, Bonilla F, Sánchez JJ and Lacal JC: Increased choline kinase activity in human breast carcinomas: Clinical evidence for a potential novel antitumor strategy. Oncogene. 21:4317–4322. 2002. View Article : Google Scholar : PubMed/NCBI
12	Glunde K, Ackerstaff E, Natarajan K, Artemov D and Bhujwalla ZM: Real-time changes in 1H and 31P NMR spectra of malignant human mammary epithelial cells during treatment with the anti-inflammatory agent indomethacin. Magn Reson Med. 48:819–825. 2002. View Article : Google Scholar : PubMed/NCBI
13	Hernández-Alcoceba R, Saniger L, Campos J, Núñez MC, Khaless F, Gallo MA, Espinosa A and Lacal JC: Choline kinase inhibitors as a novel approach for antiproliferative drug design. Oncogene. 15:2289–2301. 1997. View Article : Google Scholar : PubMed/NCBI
14	Rodríguez-González A, de Ramirez Molina A, Fernández F and Lacal JC: Choline kinase inhibition induces the increase in ceramides resulting in a highly specific and selective cytotoxic antitumoral strategy as a potential mechanism of action. Oncogene. 23:8247–8259. 2004. View Article : Google Scholar : PubMed/NCBI
15	Glunde K, Raman V, Mori N and Bhujwalla ZM: RNA interference-mediated choline kinase suppression in breast cancer cells induces differentiation and reduces proliferation. Cancer Res. 65:11034–11043. 2005. View Article : Google Scholar : PubMed/NCBI
16	Bensimon J, Altmeyer-Morel S, Benjelloun H, Chevillard S and Lebeau J: CD24(-/low) stem-like breast cancer marker defines the radiation-resistant cells involved in memorization and transmission of radiation-induced genomic instability. Oncogene. 32:251–258. 2013. View Article : Google Scholar : PubMed/NCBI
17	Curman D, Cinel B, Williams DE, Rundle N, Block WD, Goodarzi AA, Hutchins JR, Clarke PR, Zhou BB, Lees-Miller SP, et al: Inhibition of the G2 DNA damage checkpoint and of protein kinases chkl and chk2 by the marine sponge alkaloid debromohymenialdisine. J Biol Chem. 276:17914–17919. 2001. View Article : Google Scholar : PubMed/NCBI
18	Su WY and Gordon T: In vivo exposure to ozone produces an increase in a 72-kDa heat shock protein in guinea pigs. J Appl Physiol (1985). 83:707–711. 1997.PubMed/NCBI
19	Dittmann K, Mayer C, Fehrenbacher B, Schaller M, Raju U, Milas L, Chen DJ, Kehlbach R and Rodemann HP: Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase. J Biol Chem. 280:31182–31189. 2005. View Article : Google Scholar : PubMed/NCBI
20	Marín L, Minguela A, Torío A, Moya-Quiles MR, Muro M, Montes-Ares O, Parrado A, Alvarez-López DM and García-Alonso AM: Flow cytometric quantification of apoptosis and proliferation in mixed lymphocyte culture. Cytometry A. 51:107–118. 2003. View Article : Google Scholar : PubMed/NCBI
21	Chen MS, Woodward WA, Behbod F, Peddibhotla S, Alfaro MP, Buchholz TA and Rosen JM: Wnt/beta-catenin mediates radiation resistance of Sca1⁺ progenitors in an immortalized mammary gland cell line. J Cell Sci. 120:468–477. 2007. View Article : Google Scholar : PubMed/NCBI
22	Woodward WA, Chen MS, Behbod F, Alfaro MP, Buchholz TA and Rosen JM: WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc Natl Acad Sci USA. 104:618–623. 2007. View Article : Google Scholar : PubMed/NCBI
23	Sansone P, Storci G, Giovannini C, Pandolfi S, Pianetti S, Taffurelli M, Santini D, Ceccarelli C, Chieco P and Bonafé M: p66Shc/Notch-3 interplay controls self-renewal and hypoxia survival in human stem/progenitor cells of the mammary gland expanded in vitro as mammospheres. Stem Cells. 25:807–815. 2007. View Article : Google Scholar : PubMed/NCBI
24	Sancar A, Lindsey-Boltz LA, Unsal-Kaçmaz K and Linn S: Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem. 73:39–85. 2004. View Article : Google Scholar : PubMed/NCBI
25	Xiao Z, Xue J, Semizarov D, Sowin TJ, Rosenberg SH and Zhang H: Novel indication for cancer therapy: Chkl inhibition sensitizes tumor cells to antimitotice. Int J Cancer. 115:528–538. 2005. View Article : Google Scholar : PubMed/NCBI
26	Wang HC, Chou WC, Shieh SY and Shen CY: Amtaxia telangiectasia mumted and checkpoint kinase 2 regulate BRCA1 to promote the fidelity of DNA end-joining. Cancer Res. 66:1391–1400. 2006. View Article : Google Scholar : PubMed/NCBI
27	Zhuang J, Zhang J, Willers H, Wang H, Chung JH, van Gent DC, Hallahan DE, Powell SN and Xia F: Checkpoint kinase 2-mediated Phosphoryiation of BRCAl regulates the fidelity of nonhomologous end-joining. Cancer Res. 66:1401–1408. 2006. View Article : Google Scholar : PubMed/NCBI
28	Tan Y, Raychaudhuri P and Costa RH: Chk2 medistes stabilization of the FoxM1 transcription factor to stimulate expression of DNA repair genes. Mol Cell Biol. 27:1007–1016. 2007. View Article : Google Scholar : PubMed/NCBI
29	Arienti KL, Brunmark A, Axe FU, McClure K, Lee A, Blevitt J, Neff DK, Huang L, Crawford S, Pandit CR, et al: Checkpoint kinase inhibitors: SAR and radioprotective properties of aseries of 2-arylbenzimidazoles. J Med Chem. 48:1873–1885. 2005. View Article : Google Scholar : PubMed/NCBI
30	Bull EE, Dote H, Brady KJ, Burgan WE, Carter DJ, Cerra MA, Oswald KA, Hollingshead MG, Camphausen K and Tofilon PJ: Enhanced tumor cell radiosensitivity and a btogation of G2 and S phase arrest by the Hsp90 inhibitor 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin. Clin Cancer Res. 10:8077–8084. 2004. View Article : Google Scholar : PubMed/NCBI
31	Kastan MB and Bartek J: Cell-cycle checkpoints and Cancer. Nature. 432:316–323. 2004. View Article : Google Scholar : PubMed/NCBI
32	Lee JH and Paull TT: ATM activation by DNA double-strand breaks through the Mrell-Rad50-Nbs1 complex. Science. 308:551–554. 2005. View Article : Google Scholar : PubMed/NCBI
33	Reya T, Morrison SJ, Clarke MF and Weissman IL: Stem cells, cancer and cancer stem cells. Nature. 414:105–111. 2001. View Article : Google Scholar : PubMed/NCBI
34	Shah T, Wildes F, Penet MF, Winnard PT Jr, Glunde K, Artemov D, Ackerstaff E, Gimi B, Kakkad S, Raman V and Bhujwalla ZM: Choline kinase overexpression increases invasiveness and drug resistance of human breast cancer cells. NMR Biomed. 23:633–642. 2010. View Article : Google Scholar : PubMed/NCBI